Filing Details
- Accession Number:
- 0001127602-17-022095
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-06-23 16:04:14
- Reporting Period:
- 2017-06-23
- Filing Date:
- 2017-06-23
- Accepted Time:
- 2017-06-23 16:04:14
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1082554 | United Therapeutics Corp | UTHR | Pharmaceutical Preparations (2834) | 521984749 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1231617 | Raymond Dwek | C/O United Therapeutics Corporation 1040 Spring Street Silver Spring MD 20910 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2017-06-23 | 3,490 | $131.71 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- This sale of common stock was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person.
- This transaction was executed in multiple trades at prices ranging from $131.51 to 131.86. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.